Allan Moss
Angel Investor
Sydney, Australia
Allan Moss is a Series A investor in Sydney focused on Health Care and Medical Device. Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Allan Moss invests in
Stages Allan Moss invests in
Countries Allan Moss invests in
Round sizes
Round size
- Series A
- $2.3M–$8.8M
Investment Focus
Industry
- Health Care 3 (33%)
- Medical Device 3 (33%)
- Biotechnology 2 (22%)
- Travel 1 (11%)
- Medical 1 (11%)
Stage
- Series A 3 (33%)
- Funding Round 3 (33%)
- Seed 1 (11%)
- Series B 1 (11%)
- Venture - Series Unknown 1 (11%)
Country
- Australia 5 (56%)
- United States 1 (11%)
- The Netherlands 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Skykraft
|
Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation. | $3.5M / Venture - Series Unknown / Dec 07, 2021 | |
Ferronova
|
Ferronova is a medical device company that offers imaging and surgery products. | $2.3M / Series A / May 25, 2020 | |
Invert Robotics
|
Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications. | $8.8M / Series A / May 02, 2019 | |
Lumitron Technologies
|
Commercialising an X-ray technique developed within Lawrence Livermore, in conjunction with the SLAC National Accelerator Laboratory at Stanford University, which utilises a new type of high-energy laser light source (known as Laser-Compton) to recreate the power of a billion-dollar synchrotron, but in a device the size of a modern CT scanner thatwill cost a fraction of the price.Commercial Application: Aiming to replace the traditional x-ray and CT scanners in hospitals and identify problems such as tumors in far more detail. In addition, aims to create an ultra low radiation technology that can theoretically be able to treat a tumor with precision radiotherapy at the same time as imaging it. | $22.6M / Jul 09, 2018 | |
|
Invert Robotics
|
Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications. | $6.4M / Jan 30, 2018 | |
Expert360
|
Expert360 is APAC’s marketplace and management platform powering the freelance economy. The platform enables top freelance consultants, contractors and experts to easily connect with APAC’s largest businesses to perform high quality, project orientated work. Expert360’s platform allows enterprise to respond quickly to the resource demands of thebusiness while streamlining the source-to-pay freelance management life cycle at scale. | $8.8M / Series B / Jul 16, 2017 | |
Atomo Diagnostics
|
Atomo Diagnostics was established to capitalize on a core belief that health care products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants.Having identified the usability challenges and in-fieldlimitations of existing RDT products, Atomo worked closely with healthcare workers and consumers in a range of settings and determined that by integrating all the test components into a streamlined, end-to-end solution it could significantly improve safety and accuracy and reduce user error rates.This focus on usability and how end users interact with the RDT is one of the key aspects that sets Atomo apart from its competition in the POCT market.Its unique design and patented features mean that AtomoRapid™ addresses and eliminates the vast majority of user errors identified as impacting the performance of standard RDTs in the field. AtomoRapid™ makes it easy to convert proven diagnostic technologies into user-friendly products that deliver unmatched customer satisfaction and in-field performance.These products are successful due to their ability to materially improve usability, convenience, and reliability for both professional and home users. It is this unswerving focus on exceeding user expectations that the management team has applied to the diagnostic market; a market that has to date seen little user-centric innovation.Atomo Diagnostics is headquartered in Sydney, Australia, with corporate offices located in South Africa the UK. The company is led by an executive team with a track record of success commercializing disruptive healthcare products, and the company has assembled an experienced and committed international management team and Board and advisors. | $3M / Aug 11, 2016 | |
Leezair
|
Leezair connects travellers with experiences, tours and activities in 182 countries. We are a technology startup that creates innovations and integrations in order to allow travellers to experience the world more conveniently.We have 3 main departments with dedicated digital services: - Leezair Marketplace (B2B for Operators/Suppliers) -Leezair Partner Network (B2B Portal for Distributors & Agents) - Leezair Apps (B2C) | $673K / Seed / Jul 01, 2016 | |
|
Expert360
|
Expert360 is APAC’s marketplace and management platform powering the freelance economy. The platform enables top freelance consultants, contractors and experts to easily connect with APAC’s largest businesses to perform high quality, project orientated work. Expert360’s platform allows enterprise to respond quickly to the resource demands of thebusiness while streamlining the source-to-pay freelance management life cycle at scale. | $2.7M / Series A / Jul 20, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Allan Moss invest in?
Allan Moss invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 9 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Allan Moss's check size?
Allan Moss typically joins rounds of $2.3M–$8.8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Allan Moss participates in.
When did Allan Moss last invest?
The most recent investment recorded for Allan Moss closed in Dec 2021. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
